Impact of preoperative body mass index on the final outcome after laparoscopic sleeve gastrectomy for morbid obesity

Elbanna, Hosam Ghazy; Ghnnam, Wagih Mommtaz; Negm, Abdelazim; Youssef, Tamer; Emile, Sameh Hany; Metwally, Tito El; Elalfy, Khaled

doi:10.5152/ucd.2016.3275

Cited by 26 publications

(30 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our mid-term (3-year follow-up) results showed that both groups had good outcomes and that there was no significant difference in %EWL, which might be attributed to a lower initial body mass index (BMI) [37]. Hosam et al observed that the preoperative BMI had a strong impact on the final outcome of LSG [38]. Interestingly, LRYGB gradually showed its advantages during the 5-year follow-up period, which agreed with the research conclusions of Zhang et al [6].…”

Section: %Ewlmentioning

confidence: 63%

A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass

Huang

et al. 2020

BMC Surg

View full text Add to dashboard Cite

Background: Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are two representative bariatric surgeries. This study aimed to compare the effects of the LSG and LRYGB based on highquality analysis and massive amount of data.Methods: For this study databases of PubMed, Web of Science, EBSCO, Medline, and Cochrane Library were searched for articles published until January 2019 comparing the outcomes of LSG and LRYGB.Results: This study included 28 articles. Overall, 9038 patients (4597, LSG group; 4441, LRYGB group) were included. The remission rate of type 2 diabetes mellitus (T2DM) in the LRYGB group was superior to that in the LSG group at the 3-years follow-up. Five-year follow-up results showed that LRYGB had an advantage over LSG for the percentage of excess weight loss and remission of T2DM, hypertension, dyslipidemia, and abnormally low-density lipoprotein.Conclusions: In terms of the long-term effects of bariatric surgery, the effect of LRYGB was better than of LSG.

show abstract

Section: %Ewlmentioning

confidence: 63%

A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass

Huang

et al. 2020

BMC Surg

View full text Add to dashboard Cite

show abstract

“…It was found in literature that the complication rate of a GS ranges from 2.2% to 15.1%, our percentages of comorbidities is 3.20%, which is considered to be relatively low. Some authors indicate that the greater percentage of these are presented in the groups of patients with a previous bariatric surgery [7,10,11,27]; however, for us, no patient with these characteristics presented any complication.…”

Section: Discussionmentioning

confidence: 62%

“…In addition to reducing excess weight, it achieves a high rate of improvement and remission of metabolic comorbidities, which improves the quality and life expectancy of the operated patients [7]. The GS is a relatively new procedure and has become one of the bariatric procedures of choice for treating obesity [7,8,10].…”

Section: Discussionmentioning

confidence: 99%

“…The main cause relies on changing the lifestyle of modern society, which has generated a huge unbalance between the consumption and use of energy, the development of large quantity and variety of industrial foods with a high caloric density, the enormous increase of sedentary lifestyle and less physical activity [7]. Obesity currently represents a major public health issue that has a serious impact on several countries' economy, it is associated with premature mortality, chronic morbidity, an increased use of health services, life quality deterioration and social stigmatization [2,8,9]; It has become a true epidemic of the 21st century and integrates what is known as the civilization syndrome, so the World Health Organization now considers obesity as a global epidemic [1,10,11]. The prevalence of obese patients has severely increased becoming a serious public health issue [7].…”

Section: Introductionmentioning

confidence: 99%

“…Fat is a toxic factor which increases the fragility of these patients [12]; Obese people suffer from an increased risk of presenting multiple comorbidities such as high blood pressure, diabetes mellitus, dyslipidemia, heart failure, venous insufficiency, stroke, gout, COPD, coronary heart disease, obstructive sleep apnea, osteoarthritis, development of insulin resistance , osteoarticular diseases, mood disorders, substance abuse, depression, anxiety, reproductive disorders and cancer, which diminishes the quality and life expectancy [4,6,8,10,13].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Gastric Sleeve analysis as a surgical treatment for obesity

2018

IJDMD

View full text Add to dashboard Cite

Introduction: Obesity is defined as the abnormal or excessive accumulation of fat that can be harmful to health. It is estimated that about 10 million people are severely obese in Mexico. Gastric Sleeve (GS) is the main procedure performed worldwide and has shown excellent results in treating obesity. Materials and Methods: This is a retrospective study carried out by "Gastric Bypass Mexico" medical group from 2014 to 2016, where records of 1,030 patients who underwent a GS by 3 surgeons under the same technique were reviewed; Patients who were not approved by the multidisciplinary team were excluded. Results: A total of 1,032 surgeries were performed, 814 (79.03%) to women; the averages are: age - 35.01 years old; BMI 40.16Kg / m2 (30-90.56 kg / m2); intrahospital stay 1.11 (1-5) days; surgical time 20.01 (15-35) minutes, anesthetic time 37.50 (30-102) minutes. The mortality rate was 0% and the complications percentage was 3.20% (33): 20 (1.94%) patients had bleeding, of which 7 (35%) required a globular package transfusion (1-3 units); 10 (0.97%) patients had an infection in a surgical wound, 2 (0.19%) had gastropleural fistula and 1 (0.97%) patient had a gastric leak. Discussion: A GS is a safe and effective procedure for treating and controlling obesity. Compared to other techniques, a GS involves reduced anesthetic and surgical time, and offers short stays in the hospital. Conclusions: A GS offers excellent weight loss results, with a low morbidity and mortality rate.

show abstract